Indication

For the prevention of vaso-occlusive complications of Sickle Cell Disease in patients over 2 years of age.

Medicine details

Medicine name:
hydroxycarbamide (Xromi)
SMC ID:
SMC2271
Pharmaceutical company
Nova Laboratories Ltd
BNF chapter
Nutrition and blood
Submission type
Abbreviated
Publication due date:
10 August 2020